27,061 Shares in Bruker Corporation $BRKR Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Bruker Corporation (NASDAQ:BRKR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 27,061 shares of the medical research company’s stock, valued at approximately $1,629,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of BRKR. Allworth Financial LP increased its stake in shares of Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after purchasing an additional 257 shares during the last quarter. Federated Hermes Inc. lifted its stake in Bruker by 6.7% in the fourth quarter. Federated Hermes Inc. now owns 6,027 shares of the medical research company’s stock valued at $284,000 after purchasing an additional 380 shares during the last quarter. Parallel Advisors LLC lifted its stake in Bruker by 121.0% in the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 479 shares during the last quarter. State of Michigan Retirement System grew its holdings in Bruker by 1.9% during the first quarter. State of Michigan Retirement System now owns 26,693 shares of the medical research company’s stock valued at $964,000 after purchasing an additional 500 shares during the period. Finally, CWM LLC grew its holdings in Bruker by 49.8% during the fourth quarter. CWM LLC now owns 1,631 shares of the medical research company’s stock valued at $77,000 after purchasing an additional 542 shares during the period. 79.52% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on BRKR shares. Barclays boosted their target price on Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Wall Street Zen raised Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. TD Cowen restated a “hold” rating on shares of Bruker in a research note on Wednesday, July 15th. Citigroup dropped their price objective on shares of Bruker from $60.00 to $53.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Finally, UBS Group set a $60.00 target price on shares of Bruker in a research report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $56.64.

Bruker Trading Down 0.6%

NASDAQ:BRKR opened at $59.56 on Friday. Bruker Corporation has a 1 year low of $28.53 and a 1 year high of $65.30. The stock’s fifty day moving average price is $58.66 and its two-hundred day moving average price is $47.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.85 and a quick ratio of 0.92. The company has a market cap of $9.07 billion, a P/E ratio of -85.09, a P/E/G ratio of 1.83 and a beta of 1.28.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.11. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The company had revenue of $838.50 million during the quarter, compared to analysts’ expectations of $853.57 million. During the same period in the previous year, the business earned $0.32 earnings per share. The firm’s quarterly revenue was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts expect that Bruker Corporation will post 2.12 EPS for the current year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, September 21st. Bruker’s payout ratio is presently -28.57%.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.